LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022
Tag: SARS-CoV-2 Variants
Linea 1.0 COVID-19 Assay: Rapid Detection of Omicron Subvariant BA.2
January 28th, 2022
APDN Strategy to Address Omicron SARS-CoV-2 Variant
November 29th, 2021
APDN Submits FDA EUA Request for Linea™ SARS-CoV-2 Mutation Panel
October 25th, 2021
APDN Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel
May 26th, 2021
APDN Secures Amendment to MSA and 4th Blanket Purchase Order
April 26th, 2021
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
APDN Receives Purchase Order for 10,000 Linea™ COVID-19 Assay Kits
March 11th, 2021
Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel
March 9th, 2021